Fractyl Health, Inc.
GUTS
$1.50
-$0.13-7.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 93.00K | 97.00K | 119.00K | 148.00K | 120.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.00K | 97.00K | 119.00K | 148.00K | 120.00K |
| Cost of Revenue | 50.00K | 52.00K | 70.00K | 93.00K | 77.00K |
| Gross Profit | 43.00K | 45.00K | 49.00K | 55.00K | 43.00K |
| SG&A Expenses | 23.10M | 20.99M | 20.70M | 17.21M | 12.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.62M | 81.40M | 71.50M | 60.42M | 50.96M |
| Operating Income | -93.53M | -81.30M | -71.38M | -60.27M | -50.84M |
| Income Before Tax | -68.69M | -62.90M | -55.48M | -68.48M | -77.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -68.69 | -62.90 | -55.48 | -68.48 | -77.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.69M | -62.90M | -55.48M | -68.48M | -77.09M |
| EBIT | -93.53M | -81.30M | -71.38M | -60.27M | -50.84M |
| EBITDA | -92.85M | -80.81M | -71.01M | -60.01M | -50.52M |
| EPS Basic | -1.53 | -12.20 | -21.32 | -37.58 | -45.27 |
| Normalized Basic EPS | -1.01 | -6.10 | -10.22 | -13.57 | -16.91 |
| EPS Diluted | -1.53 | -12.20 | -21.32 | -37.58 | -45.27 |
| Normalized Diluted EPS | -1.01 | -6.10 | -10.22 | -13.57 | -16.91 |
| Average Basic Shares Outstanding | 174.06M | 127.71M | 81.83M | 36.01M | 8.32M |
| Average Diluted Shares Outstanding | 174.06M | 127.71M | 81.83M | 36.01M | 8.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |